Indian J Med Res 123(3) March 2006 : 193-480



Guest Editors : Dr C.P. Thakur & Dr S.K. Bhattacharya


Leishmaniasis research - the challenges ahead
C.P. Thakur 

Elimination of leishmaniasis (kala-azar) from the Indian subcontinent is technically feasible & operationally achievable
S.K. Bhattacharya, Dipika Sur, P.K. Sinha & Juntra Karbwang 

Original Article

Pre- & post-treatment evaluation of immunological features in Indian visceral leishmaniasis (VL) patients with HIV co-infection
P.K. Sinha, Sanjiva Bimal, S.K. Singh, Krishna Pandey
D.N. Gangopadhyay & S.K. Bhattacharya 

Review Articles

Biology of Leishmania donovani

Glycobiology of Leishmania donovani
Sumi Mukhopadhyay
(nee Bandyopadhyay) & Chitra Mandal 

Topoisomerase research of kinetoplastid parasite Leishmania, with special reference to development of therapeutics
Benu Brata Das, Nilkantha Sen, Somdeb Bose Dasgupta, Agneyo Ganguly
Rakhee Das & Hemanta K. Majumder

Apoptosis in Leishmania species & its relevance to disease pathogenesis
Chandrima Shaha 

Immune responses in kala-azar
Samiran Saha, Smriti Mondal, Antara Banerjee, Jayeeta Ghose
Sudipta Bhowmick & Nahid Ali 

Pathophysiology of visceral leishmaniasis - some recent concepts
Nancy Malla & R.C. Mahajan 


The epidemiology of visceral leishmaniasis in Bangladesh: Prospects for improved control
Caryn Bern & Rajib Chowdhury 

Visceral leishmaniasis in the New World & Africa
Jonathan Berman


Challenges in the diagnosis of post kala-azar dermal leishmaniasis
Poonam Salotra & Ruchi Singh 

New developments in diagnosis of leishmaniasis
Sarman Singh 

Visceral leishmaniasis (kala-azar): Challenges ahead
R.K. Singh, H.P. Pandey & S. Sundar 

Clinical Studies

Visceral leishmaniasis - current therapeutic modalities
Shyam Sundar & Mitali Chatterjee 

Childhood visceral leishmaniasis
S.K. Bhattacharya, Dipika Sur & Juntra Karbwang 

Leishmania/HIV co-infections in the second decade
Israel Cruz, Javier Nieto, Javier Moreno, Carmen Caņavate
Philippe Desjeux & Jorge Alvar 

Drug unresponsiveness & combination therapy for kala-azar
T.K. Jha 

Current scenario of drug development for leishmaniasis
Simon L. Croft, Karin Seifert & Vanessa Yardley 

Drug resistance mechanisms in clinical isolates of Leishmania donovani 
Neeloo Singh 


Leishmaniasis vaccine candidates for development: A global overview
Ali Khamesipour, Sima Rafati, Noushin Davoudi, Fereidoun Maboudi
& Farrokh Modabber 

Animal models for vaccine studies for visceral leishmaniasis
Ravendra Garg & Anuradha Dube

Genetically modified live attenuated parasites as vaccines for leishmaniasis
Angamuthu Selvapandiyan, Robert Duncan, Alain Debrabant, Nancy Lee
G. Sreenivas, Poonam Salotra & Hira L. Nakhasi 

Vector control in leishmaniasis
K. Kishore, V. Kumar, S. Kesari, D.S. Dinesh, A.J. Kumar
P. Das & S.K. Bhattacharya


Prevalence of visceral leishmania & HIV co-infection in Nepal
R.L. Gurubacharya, S.M. Gurubacharya, D.L. Gurubacharya
J. Quinkel & V.L. Gurubacharya 

Classics in Leishmaniasis Research

History of kala-azar in India
P.C. Sen Gupta
(The Indian Medical Gazett
e; May 1947; 281-6)

On the possibility of the occurrence of trypanosomiasis in India
Major W.B. Leishman
(The British Medical Journa
l; May 30, 1903; 1252-4)

Memoranda :On the possibility of the occurrence of trypanosomiasis in India
C. Donovan
(The British Medical Journa
l; July 11, 1903; 79)

Transmission of Indian kala-azar to man by the bites of Phlebotomus argentipes Ann. and Burn
C.S. Swaminath, H.E. Shortt & L.A.P. Anderson
(Indian J Med Res,
July 1942; 30 : 473-7)

Book Review

Trends and research in Leishmaniasis, with particular reference to kala-azar

Book Received

Some Forthcoming Scientific Events 


Guidelines for Contributors 

Home Page